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INTRODUCTION
Chronic lymphocytic leukemia (CLL) is a 
proliferative malignancy that can infiltrate 
multiple different organs throughout the human 
body. Even though CLL is one of the most 
common forms of leukemia in the adult 
population, it has been previously been reported 
to rarely affect the liver. Since the development 
of more advanced biologic and chemotherapy 
medications, patients are presenting with more 
rare presentations of common disease 
processes.1,2 Now that metastatic CLL is 
becoming more prevalent, we need to 
consider previously documented rare sites of 
metastasis as potential sites of disease.2,3
CASE PRESENTATION
A 76 year-old male with a past medical history 
of CLL (+13q14 mutation) and CKD was 
evaluated for elevated liver enzymes. He was 
found to have an AST of 112, ALT of 348, 
ferritin of 953 along with a transferrin saturation 
of 27%. During his extensive evaluation, a CT 
of his abdomen and pelvis revealed worsening 
intraabdominal lymphadenopathy. Additional 
imaging with an abdominal ultrasound 
revealed worsening hepatomegaly and 
splenomegaly. Additional causes of his 
findings were evaluated, however blood work 
showed a negative ANA/SMA/AMA, a negative 
HAV/HBV/HCV. Percutaneous liver biopsy was 
performed for further evaluation, which showed 
involvement of his liver with dense lymphoid 
infiltrate of the portal tracts, consistent with 
chronic lymphocytic leukemia (CLL). This liver 
biopsy was similar in nature to his previous 
bone marrow biopsy. The patient was initiated 
on Imbruvica and soon thereafter, his liver 
function tests improved. He continues to  
follow with Oncology for his CLL. 
DISCUSSION
Though there are many different reasons why 
the liver is becoming more commonly affected, 
this rise in incidence shines a new light on 
chronic liver disease management. Even though 
liver infiltration with CLL has not been studied 
as much as other organ systems, this spike in 
disease incidence should make us all aware of 
these complications. Properly diagnosing this 
rare complication of CLL in a timely manner 
would allow our patients to have better outcomes 
as well as provide physicians a better clinical 
understanding of this disease process.2,3
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Figure 1: The official pathology report showing CLL infiltrating the liver parenchyma.
Figure 3: This is the most up to date labs 
showing near resolution of the elevated LFTs.
Figure 2: This was the initial lab work 
that prompted additional workup of 
the elevated LFTs.
